Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.

NCT01320345 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT01320345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01320345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
Lead sponsor
University of Sydney
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 3, 2016
Completion date
December 31, 2026
Enrollment
412 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathies, diabetic retinopathy, type 1 diabetes mellitus